Back
Update on Use of Immunotherapy in Hematologic Malignancies
Update on Use of Immunotherapy in Hematologic Malignancies
Episodes
All
All
Advertisement
Advertisement
Trending on OncLive
1
Dr Mesa on the FDA Approval of Ropeginterferon Alfa-2b for Essential Thrombocythemia
2
Savolitinib Plus Osimertinib Improves First-Line PFS in MET-Overexpressing EGFR-Mutated NSCLC
3
Zanidatamab Plus Chemotherapy Improves OS at Second Interim Analysis of HERIZON-GEA-01 in First-Line HER2+ GEA
4
TTFields Add a New Dimension to the Changing Pancreatic Cancer Treatment Paradigm
5